CoChat

YAP/TAZ enhances P-body formation to promote tumorigenesis

Shen, Xia, Peng, Xiang, Guo, YueGui, Dai, Zhujiang, Cui, Long, Yu, Wei, Liu, Yun, Liu, Chen-Ying · 2024 · eLife

Published version of a preprint

Cited by 14

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The role of processing bodies (P-bodies) in tumorigenesis and tumor progression is not well understood. Here, we showed that the oncogenes YAP/TAZ promote P-body formation in a series of cancer cell lines. Mechanistically, both transcriptional activation of the P-body-related genes SAMD4A, AJUBA , and WTIP and transcriptional suppression of the tumor suppressor gene PNRC1 are involved in enhancing the effects of YAP/TAZ on P-body formation in colorectal cancer (CRC) cells. By reexpression of PNRC1 or knockdown of P-body core genes ( DDX6, DCP1A, and LSM14A ), we determined that disruption of P-bodies attenuates cell proliferation, cell migration, and tumor growth induced by overexpression of YAP 5SA in CRC. Analysis of a pancancer CRISPR screen database (DepMap) revealed co-dependencies between YAP/TEAD and the P-body core genes and correlations between the mRNA levels of SAMD4A, AJUBA, WTIP, PNRC1, and YAP target genes. Our study suggests that the P-body is a new downstream effector of YAP/TAZ, which implies that reexpression of PNRC1 or disruption of P-bodies is a potential therapeutic strategy for tumors with active YAP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.88573

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Aizer, 2013, The P body protein Dcp1a is hyper-phosphorylated during mitosis, PLOS ONE, 8, 10.1371/journal.pone.0049783 · DOI
  2. Anderson, 2015, Stress granules, P-bodies and cancer, Biochimica et Biophysica Acta, 1849, 861, 10.1016/j.bbagrm.2014.11.009 · DOI · Paper page
  3. Baez, 2005, Mammalian Smaug is a translational repressor that forms cytoplasmic foci similar to stress granules, The Journal of Biological Chemistry, 280, 43131, 10.1074/jbc.M508374200 · DOI · Paper page
  4. Bearss, 2021, EDC3 phosphorylation regulates growth and invasion through controlling P‐body formation and dynamics, EMBO Reports, 22, 10.15252/embr.202050835 · DOI
  5. Calses, 2019, Hippo pathway in cancer: aberrant regulation and therapeutic opportunities, Trends in Cancer, 5, 297, 10.1016/j.trecan.2019.04.001 · DOI · Paper page
  6. Castle, 2021, Viral manipulation of a mechanoresponsive signaling axis disassembles processing bodies, Molecular and Cellular Biology, 41, 10.1128/MCB.00399-21 · DOI
  7. Chen, 2016, Ajuba phosphorylation by CDK1 promotes cell proliferation and tumorigenesis, Journal of Biological Chemistry, 291, 14761, 10.1074/jbc.M116.722751 · DOI
  8. Chiang, 2013, Phosphorylation of mRNA decapping protein Dcp1a by the ERK signaling pathway during early differentiation of 3T3-L1 preadipocytes, PLOS ONE, 8, 10.1371/journal.pone.0061697 · DOI
  9. Das Thakur, 2010, Ajuba LIM proteins are negative regulators of the Hippo signaling pathway, Current Biology, 20, 657, 10.1016/j.cub.2010.02.035 · DOI · Paper page
  10. Decker, 2012, P-bodies and stress granules: possible roles in the control of translation and mRNA degradation, Cold Spring Harbor Perspectives in Biology, 4, 10.1101/cshperspect.a012286 · DOI · Paper page
  11. Dempster, 2021, Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects, Genome Biology, 22, 10.1186/s13059-021-02540-7 · DOI · Paper page
  12. Di Stefano, 2019, The RNA Helicase DDX6 controls cellular plasticity by modulating P-body homeostasis, Cell Stem Cell, 25, 622, 10.1016/j.stem.2019.08.018 · DOI · Paper page
  13. Driskill, 2021, The hippo pathway in liver homeostasis and pathophysiology, Annual Review of Pathology, 16, 299, 10.1146/annurev-pathol-030420-105050 · DOI · Paper page
  14. Dupont, 2011, Role of YAP/TAZ in mechanotransduction, Nature, 474, 179, 10.1038/nature10137 · DOI · Paper page
  15. Fan, 2013, Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1, PNAS, 110, 2569, 10.1073/pnas.1216462110 · DOI · Paper page
  16. Gaviraghi, 2018, Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus, The EMBO Journal, 37, 10.15252/embj.201899179 · DOI
  17. Gay, 2017, Giving AXL the axe: targeting AXL in human malignancy, British Journal of Cancer, 116, 415, 10.1038/bjc.2016.428 · DOI · Paper page
  18. Guo, 2022, CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis, Nature Communications, 13, 10.1038/s41467-022-32674-6 · DOI
  19. Hanahan, 2022, Hallmarks of cancer: new dimensions, Cancer Discovery, 12, 31, 10.1158/2159-8290.CD-21-1059 · DOI · Paper page
  20. Hardy, 2017, Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy, Oncotarget, 8, 103302, 10.18632/oncotarget.21871 · DOI · Paper page
  21. He, 2020, A regulation loop between YAP and NR4A1 balances cell proliferation and apoptosis, Cell Reports, 33, 10.1016/j.celrep.2020.108284 · DOI
  22. Hubstenberger, 2017, P-Body purification reveals the condensation of repressed mRNA Regulons, Molecular Cell, 68, 144, 10.1016/j.molcel.2017.09.003 · DOI · Paper page
  23. James, 2010, LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing, PNAS, 107, 12499, 10.1073/pnas.0914987107 · DOI
  24. Jang, 2017, Mechanical cue-induced YAP instructs Skp2-dependent cell cycle exit and oncogenic signaling, The EMBO Journal, 36, 2510, 10.15252/embj.201696089 · DOI
  25. Jin, 2021, YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression, Cell Death & Disease, 12, 10.1038/s41419-021-03722-8 · DOI
  26. Kim, 2011, E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components, PNAS, 108, 11930, 10.1073/pnas.1103345108 · DOI · Paper page
  27. Kim, 2015, Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking, Nature Communications, 6, 10.1038/ncomms7781 · DOI · Paper page
  28. Kim, 2015, Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ, Cell Reports, 11, 270, 10.1016/j.celrep.2015.03.015 · DOI · Paper page
  29. Kim, 2019, Hippo signaling is intrinsically regulated during cell cycle progression by APC/C Cdh1, PNAS, 116, 9423, 10.1073/pnas.1821370116 · DOI
  30. Kulkarni, 2020, The hippo pathway as a driver of select human cancers, Trends in Cancer, 6, 781, 10.1016/j.trecan.2020.04.004 · DOI
  31. Lavalée, 2021, Cancer cell adaptability: turning ribonucleoprotein granules into targets, Trends in Cancer, 7, 902, 10.1016/j.trecan.2021.05.006 · DOI
  32. Lee, 2018, Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner, Nature Communications, 9, 10.1038/s41467-018-04757-w · DOI
  33. Luo, 2018, P-bodies: composition, properties, and functions, Biochemistry, 57, 2424, 10.1021/acs.biochem.7b01162 · DOI · Paper page
  34. Martínez, 2013, Screening of small molecules affecting mammalian P-body assembly uncovers links with diverse intracellular processes and organelle physiology, RNA Biology, 10, 1661, 10.4161/rna.26851 · DOI
  35. Mason, 2019, YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility, The Journal of Cell Biology, 218, 1369, 10.1083/jcb.201806065 · DOI · Paper page
  36. Mei, 2017, Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse, Nucleic Acids Research, 45, D658, 10.1093/nar/gkw983 · DOI · Paper page
  37. Misra, 2018, The hippo signaling network and its biological functions, Annual Review of Genetics, 52, 65, 10.1146/annurev-genet-120417-031621 · DOI · Paper page
  38. Nagaraj, 2012, Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway, Genes & Development, 26, 2027, 10.1101/gad.183061.111 · DOI
  39. Neesse, 2013, CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer, PNAS, 110, 12325, 10.1073/pnas.1300415110 · DOI · Paper page
  40. Pei, 2022, Increased Expression of YAP Inhibited the autophagy level by upregulating mTOR Signal in the Eutopic ESCs of Endometriosis, Frontiers in Endocrinology, 13, 10.3389/fendo.2022.813165 · DOI
  41. Pelletier, 2018, Ribosome biogenesis in cancer: new players and therapeutic avenues, Nature Reviews Cancer, 18, 51, 10.1038/nrc.2017.104 · DOI · Paper page
  42. Piccolo, 2014, The biology of YAP/TAZ: hippo signaling and beyond, Physiological Reviews, 94, 1287, 10.1152/physrev.00005.2014 · DOI · Paper page
  43. Qiao, 2017, YAP regulates actin dynamics through ARHGAP29 and promotes metastasis, Cell Reports, 19, 1495, 10.1016/j.celrep.2017.04.075 · DOI · Paper page
  44. Rausch, 2019, The hippo pathway regulates caveolae expression and mediates flow response via caveolae, Current Biology, 29, 242, 10.1016/j.cub.2018.11.066 · DOI
  45. Riggs, 2020, Mammalian stress granules and P bodies at a glance, Journal of Cell Science, 133, 10.1242/jcs.242487 · DOI · Paper page
  46. Russell, 2022, Hippo signalling in the liver: role in development, regeneration and disease, Nature Reviews. Gastroenterology & Hepatology, 19, 297, 10.1038/s41575-021-00571-w · DOI · Paper page
  47. Shen, 2015, YAP Regulates S-phase entry in endothelial cells, PLOS ONE, 10, 10.1371/journal.pone.0117522 · DOI
  48. Shreberk-Shaked, 2020, A Division of Labor between YAP and TAZ in non-small cell lung cancer, Cancer Research, 80, 4145, 10.1158/0008-5472.CAN-20-0125 · DOI · Paper page
  49. Stribinskis, 2007, Rpm2p, a protein subunit of mitochondrial RNase P, physically and genetically interacts with cytoplasmic processing bodies, Nucleic Acids Research, 35, 1301, 10.1093/nar/gkm023 · DOI
  50. Sun, 2016, Cellular organization and cytoskeletal regulation of the hippo signaling network, Trends in Cell Biology, 26, 694, 10.1016/j.tcb.2016.05.003 · DOI · Paper page
  51. Totaro, 2019, Cell phenotypic plasticity requires autophagic flux driven by YAP/TAZ mechanotransduction, PNAS, 116, 17848, 10.1073/pnas.1908228116 · DOI
  52. Tsherniak, 2017, Defining a cancer dependency map, Cell, 170, 564, 10.1016/j.cell.2017.06.010 · DOI · Paper page
  53. Wang, 2020, Emerging role of the Hippo pathway in autophagy, Cell Death & Disease, 11, 10.1038/s41419-020-03069-6 · DOI
  54. Wu, 2018, Overexpression of mRNA-decapping enzyme 1a affects survival rate in colorectal carcinoma, Oncology Letters, 16, 1095, 10.3892/ol.2018.8730 · DOI
  55. Wu, 2018, MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation, Molecular Carcinogenesis, 57, 1421, 10.1002/mc.22868 · DOI · Paper page
  56. Yang, 2004, GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation, Journal of Cell Science, 117, 5567, 10.1242/jcs.01477 · DOI · Paper page
  57. Yang, 2013, CDK1 Phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation, Cancer Research, 73, 6722, 10.1158/0008-5472.CAN-13-2049 · DOI · Paper page
  58. Yoon, 2010, Dcp2 phosphorylation by Ste20 modulates stress granule assembly and mRNA decay in Saccharomyces cerevisiae, The Journal of Cell Biology, 189, 813, 10.1083/jcb.200912019 · DOI
  59. Yu, 2012, Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling, Cell, 150, 780, 10.1016/j.cell.2012.06.037 · DOI · Paper page
  60. Zhao, 2007, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control, Genes & Development, 21, 2747, 10.1101/gad.1602907 · DOI · Paper page
  61. Zhu, 2019, A Non-canonical Role of YAP/TEAD Is required for activation of estrogen-regulated enhancers in breast cancer, Molecular Cell, 75, 791, 10.1016/j.molcel.2019.06.010 · DOI · Paper page
  62. Zhu, 2020, LAMB3 promotes tumour progression through the AKT–FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer, Oncogene, 39, 4666, 10.1038/s41388-020-1321-5 · DOI
  63. Guo Y, Zhu Z, Liu C. 2022. Identification of differential expressed genes after HHEX/YAP/TAZ/TEAD knockdown in colorectal cancer cells. NCBI Gene Expression Omnibus. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE176475. GSE176475.

Cited by

See all 14

Metadata

Authors
Shen, X., Peng, X., Guo, Y., Dai, Z., Cui, L., Yu, W., Liu, Y., & Liu, C.-Y.
Affiliations
  • Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University
Venue
eLife
Published
2024-07-24
Volume
12
ISSN
2050-084X
Cited by
14
References
15
Language
en
Funders
  • National Natural Science Foundation of China (82172916, 82073056, 82273022, 82372648)
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.